Miyanishi K, Kinouchi T, Kataoka K, Kanoh T, Ohnishi Y
Department of Bacteriology, School of Medicine, the University of Tokushima, Japan.
Carcinogenesis. 1996 Jul;17(7):1483-90. doi: 10.1093/carcin/17.7.1483.
Consumption of fossil fuels has increased indoor and outdoor concentrations of polycyclic aromatic hydrocarbons (PAHs) and nitrogen dioxide (NO2). To study the combined effect of PAH administration and NO2 exposure on mutagenicity of urine from animals we injected 400 mg/kg body wt i.p. one of five kinds of PAH (pyrene, fluoranthene, fluorene, anthracene and chrysene) into ICR mice, Wistar rats, Syrian golden hamsters or Hartley guinea pigs after exposure to 20 p.p.m. NO2 gas for 24 h and then exposed the animals to NO2 gas for an additional 24 h. During the latter 24 h we collected the urine and assayed its mutagenicity with the Ames Salmonella strains after treatment with beta-glucuronidase and arylsulfatase and extraction with dichloromethane. The urine from mice treated with both PAH and NO2 showed high mutagenicity for Salmonella typhimurium strains TA98 and TA100, whereas the urine from mice treated with PAH and air showed almost no mutagenic activity. The mutagenicity was decreased in nitroreductase- and acetyltransferase-deficient strains TA98NR and TA98/1,8-DNP6 respectively. Treatment with a mixture of 20% of each of the five kinds of PAH and NO2 augmented the urinary mutagenicity of mice 1.5-fold. The urine from hamsters treated with pyrene or fluoranthene and NO2 was also highly mutagenic, but that from rats or guinea pigs was not very mutagenic. The mutagenicity was also decreased in strains TA98NR and TA98/1,8-DNP6. These results suggest that the urine contains nitro compounds and that the nitration of PAHs occurs in the body of animals under exposure to NO2 gas. Actually, the nitrated metabolites of pyrene, 1-nitro-6/8-hydroxypyrene and 1-nitro-3-hydroxypyrene, were detected in the urine from mice treated with pyrene under exposure to NO2 gas. To elucidate the mechanism of in vivo nitration, NO2 (20 p.p.m.) was bubbled through 50 mM Tris-HCl buffer (pH 7.4) or dichloromethane solution containing pyrene or 1-hydroxypyrene (10 microg/ml). Pyrene was not nitrated by NO2 in either aqueous or organic solutions. However, 1-hydroxypyrene was changed to nitrohydroxypyrenes by NO2 in the Tris-HCl buffer, but not in the organic solution. Ascorbic acid, alpha-tocopherol, glutathione oleic acid and hemoglobin were found to inhibit the nitration of 1-hydroxypyrene in aqueous solution. The urinary mutagenicity of mice treated with both pyrene and NO2 was also decreased by oral administration of ascorbic acid and alpha-tocopherol. These results suggest that 1-hydroxypyrene is nitrated by an ionic reaction in the animal body after hydroxylation of pyrene in the liver.
化石燃料的消耗增加了室内和室外多环芳烃(PAHs)及二氧化氮(NO₂)的浓度。为研究PAH给药与NO₂暴露对动物尿液致突变性的联合作用,我们在将20 ppm NO₂气体暴露24小时后,给ICR小鼠、Wistar大鼠、叙利亚金黄地鼠或Hartley豚鼠腹腔注射400 mg/kg体重的五种PAH(芘、荧蒽、芴、蒽和 Chrysene)中的一种,然后再将动物暴露于NO₂气体中24小时。在这后24小时内,我们收集尿液,用β-葡萄糖醛酸酶和芳基硫酸酯酶处理并经二氯甲烷萃取后,用Ames沙门氏菌菌株检测其致突变性。同时接受PAH和NO₂处理的小鼠尿液对鼠伤寒沙门氏菌TA98和TA100菌株显示出高致突变性,而仅接受PAH和空气处理的小鼠尿液几乎没有致突变活性。在缺乏硝基还原酶和乙酰转移酶的TA98NR和TA98/1,8-DNP6菌株中,致突变性分别降低。用五种PAH各20%的混合物与NO₂处理可使小鼠尿液致突变性增加1.5倍。用芘或荧蒽与NO₂处理的地鼠尿液也具有高致突变性,但大鼠或豚鼠的尿液致突变性不强。在TA98NR和TA98/1,8-DNP6菌株中致突变性也降低。这些结果表明尿液中含有硝基化合物,并且在暴露于NO₂气体的动物体内PAHs会发生硝化反应。实际上,在暴露于NO₂气体下用芘处理的小鼠尿液中检测到了芘的硝化代谢产物1-硝基-6/8-羟基芘和1-硝基-3-羟基芘。为阐明体内硝化的机制,将NO₂(20 ppm)通入含有芘或1-羟基芘(10 μg/ml)的50 mM Tris-HCl缓冲液(pH 7.4)或二氯甲烷溶液中。芘在水溶液或有机溶液中均未被NO₂硝化。然而,1-羟基芘在Tris-HCl缓冲液中被NO₂转变为硝基羟基芘,但在有机溶液中未发生转变。发现抗坏血酸、α-生育酚、谷胱甘肽油酸和血红蛋白可抑制水溶液中1-羟基芘的硝化。口服抗坏血酸和α-生育酚也可降低同时接受芘和NO₂处理的小鼠尿液的致突变性。这些结果表明芘在肝脏中羟基化后,1-羟基芘在动物体内通过离子反应被硝化。